Recent history of White House proposed cuts to tuberculosis programming and research raise questions on status of Administration plan for MDR-TB A Huffington Post article last week described the individual impact, the economic damage and the global threat of drug-resistant tuberculosis in stark and efficient terms, starting with the case of one woman in the U.S., a teacher […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]